671 related articles for article (PubMed ID: 9726240)
21. The decrease in phosphatidylinositol 4,5-bisphosphate in ADP-stimulated washed rabbit platelets is not primarily due to phospholipase C activation.
Vickers JD; Kinlough-Rathbone RL; Mustard JF
Biochem J; 1986 Jul; 237(2):327-32. PubMed ID: 3026316
[TBL] [Abstract][Full Text] [Related]
22. AMP-Activated Protein Kinase Mediates the Antiplatelet Effects of the Thiazolidinediones Rosiglitazone and Pioglitazone.
Liu Y; Park JM; Chang KH; Huh HJ; Lee K; Lee MY
Mol Pharmacol; 2016 Feb; 89(2):313-21. PubMed ID: 26643379
[TBL] [Abstract][Full Text] [Related]
23. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
[TBL] [Abstract][Full Text] [Related]
24. Functional implications of tyrosine protein phosphorylation in platelets. Simultaneous studies with different agonists and inhibitors.
Bachelot C; Cano E; Grelac F; Saleun S; Druker BJ; Levy-Toledano S; Fischer S; Rendu F
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):923-8. PubMed ID: 1622407
[TBL] [Abstract][Full Text] [Related]
25. Thrombin-induced abnormal platelet activation in spontaneously hypertensive rats is linked with phosphoinositides turnover and phosphorylation of 47,000 and 20,000 dalton proteins.
Huzoor-Akbar ; Anwer K
Thromb Res; 1988 Jan; 49(1):5-21. PubMed ID: 2831638
[TBL] [Abstract][Full Text] [Related]
26. Thrombin-stimulated phosphatidylinositol 3-kinase activity in platelets is associated with activation of PYK2 tyrosine kinase: activation of both enzymes is aggregation independent.
Sayed MR; Sheid MP; Stevens CM; Duronio V
J Cell Physiol; 2000 Jun; 183(3):314-20. PubMed ID: 10797305
[TBL] [Abstract][Full Text] [Related]
27. Phosphoinositide breakdown as an indirect link between stimulation and aggregation of rat platelets by thrombin and collagen.
Kito M; Narita H; Ishinaga M; Park HJ; Takamura H
J Biochem; 1985 Mar; 97(3):765-72. PubMed ID: 2991207
[TBL] [Abstract][Full Text] [Related]
28. alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism.
Freedman JE; Farhat JH; Loscalzo J; Keaney JF
Circulation; 1996 Nov; 94(10):2434-40. PubMed ID: 8921785
[TBL] [Abstract][Full Text] [Related]
29. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets.
Vickers JD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627
[TBL] [Abstract][Full Text] [Related]
30. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
31. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
32. Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats.
Fujiwara T; Ohsawa T; Takahashi S; Ikeda K; Okuno A; Ushiyama S; Matsuda K; Horikoshi H
Life Sci; 1998; 63(22):2039-47. PubMed ID: 9839548
[TBL] [Abstract][Full Text] [Related]
33. Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes.
Bähr M; Spelleken M; Bock M; von Holtey M; Kiehn R; Eckel J
Diabetologia; 1996 Jul; 39(7):766-74. PubMed ID: 8817100
[TBL] [Abstract][Full Text] [Related]
34. Neomycin inhibits agonist-stimulated polyphosphoinositide metabolism and responses in human platelets.
Tysnes OB; Verhoeven AJ; Holmsen H
Biochem Biophys Res Commun; 1987 Apr; 144(1):454-62. PubMed ID: 3034251
[TBL] [Abstract][Full Text] [Related]
35. Effects of chlorpromazine on phosphatidylinositol turnover following thrombin stimulation of human platelets.
Wakatabe H; Tsukahara T; Ishigooka J; Miura S
Biol Psychiatry; 1991 May; 29(10):965-78. PubMed ID: 1905965
[TBL] [Abstract][Full Text] [Related]
36. PDGF modifies phosphoinositide metabolism and inhibits aggregation and release in human platelets.
Bryckaert MC; Rendu F; Tobelem G; Caen J
Biochem Biophys Res Commun; 1986 Feb; 135(1):52-7. PubMed ID: 3006686
[TBL] [Abstract][Full Text] [Related]
37. Erbstatin blocks platelet activating factor-induced protein-tyrosine phosphorylation, polyphosphoinositide hydrolysis, protein kinase C activation, serotonin secretion and aggregation of rabbit platelets.
Salari H; Duronio V; Howard SL; Demos M; Jones K; Reany A; Hudson AT; Pelech SL
FEBS Lett; 1990 Apr; 263(1):104-8. PubMed ID: 1691984
[TBL] [Abstract][Full Text] [Related]
38. The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M
Acta Pol Pharm; 2009; 66(3):235-42. PubMed ID: 19645323
[TBL] [Abstract][Full Text] [Related]
39. Pyridoxine increases nitric oxide biosynthesis in human platelets.
Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y
Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
